Sperling Prostate Center

Month: December 2020

Artificial Intelligence in Medicine: Predicting Risk of Heart Attack or Stroke Based on CT Scans

Artificial Intelligence Predicting Risk of Heart Attack or Stroke Based on CT Scans | Sperling Prostate Center
These days, it’s more important than even to protect your personal privacy and keep your information secure. Every day, we hear about identity theft, hackers, cybercrime, and security breaches. Just the thought of a thief or cyberattack penetrating not only our individual virus protection, firewalls, etc. but also those of our banking security or credit keep reading

A First-of-its-Kind Vaccine to Prevent Prostate Cancer Recurrence

Prostate Cancer Vaccine | Sperling Prostate Center
Here is fantastic news for men who undergo an initial treatment for localized prostate cancer! In November, 2020 the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to RV001, an investigational vaccine against prostate cancer recurrence after primary treatment. RV001 is manufactured by a Swedish pharmaceutical company called RhoVac. Let’s look at the keep reading
WordPress Image Lightbox